Company Filing History:
Years Active: 2022-2023
Title: The Innovative Contributions of Inventor Alex Micka
Introduction
Alex Micka, an accomplished inventor based in Hazelwood, MO, has made significant strides in the pharmaceutical sector through his innovative creations. With three patents to his name, Micka focuses on developing formulations that address critical health challenges, particularly in the area of abuse deterrence in medication.
Latest Patents
Micka's latest patents include groundbreaking pharmaceutical compositions that comprise non-cellulose polysaccharides. These inventions provide immediate release of active ingredients while also incorporating abuse deterrent properties. His first patent introduces a composition that includes at least one pharmaceutically active ingredient, one non-cellulose polysaccharide, a hydrophilic gelling polymer, and an effervescent system. The innovative approach not only addresses the efficacy of medications but also aims to mitigate the risk of misuse.
Career Highlights
Throughout his career, Alex Micka has been associated with Specgx LLC, a company known for its commitment to advancing pharmaceutical development. His work at Specgx has enabled him to leverage his skills and creativity to develop solutions that have the potential to make a real difference in patient care.
Collaborations
Micka collaborates with talented colleagues, including Kai Feng and Tsz Chung Lai, who contribute their expertise to further enhance the development of effective pharmaceutical compositions. Together, they form a collaborative team that shares a common goal of innovating within the healthcare industry.
Conclusion
In summary, inventor Alex Micka stands out in the field of pharmaceutical innovation. With three impactful patents to his name, he continues to push boundaries in creating immediate-release formulations aimed at enhancing patient safety. His work at Specgx LLC, along with fruitful collaborations, positions him as a significant contributor to advancements in medicine.